Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA32248
Max Phase: Preclinical
Molecular Formula: C28H28N4O4
Molecular Weight: 484.56
Molecule Type: Small molecule
Associated Items:
ID: ALA32248
Max Phase: Preclinical
Molecular Formula: C28H28N4O4
Molecular Weight: 484.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OCc1ccccc1
Standard InChI: InChI=1S/C28H28N4O4/c29-26(33)24(15-19-9-3-1-4-10-19)31-27(34)25(16-21-17-30-23-14-8-7-13-22(21)23)32-28(35)36-18-20-11-5-2-6-12-20/h1-14,17,24-25,30H,15-16,18H2,(H2,29,33)(H,31,34)(H,32,35)/t24-,25-/m0/s1
Standard InChI Key: MOFIHHRIGQKWJP-DQEYMECFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 484.56 | Molecular Weight (Monoisotopic): 484.2111 | AlogP: 3.22 | #Rotatable Bonds: 10 |
Polar Surface Area: 126.31 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.46 | CX Basic pKa: | CX LogP: 3.65 | CX LogD: 3.65 |
Aromatic Rings: 4 | Heavy Atoms: 36 | QED Weighted: 0.28 | Np Likeness Score: -0.25 |
1. Horwell DC, Howson W, Naylor D, Wilems HM. (1995) The design of polar -turn dipeptide mimetics, 5 (14): [10.1016/0960-894X(95)00254-Q] |
2. Horwell DC, Morrell AI, Roberts E. (1996) The design and synthesis of non-peptide ligands with affinity and selectivity for tachykinin receptors, 6 (2): [10.1016/0960-894X(95)00582-E] |
3. Horwell DC, Howson W, Ratcliffe G, Willems H. (1994) The design of dipeptide helical mimetics: the synthesis and biological activity of trisubstituted indanes, 4 (24): [10.1016/S0960-894X(01)80821-0] |
Source(1):